.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Cipla
Accenture
Daiichi Sankyo
Chubb
Merck
Novartis
US Army
Chinese Patent Office

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018632

« Back to Dashboard

NDA 018632 describes STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Icu Medical Inc, and Taro, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the STERILE WATER FOR INJECTION IN PLASTIC CONTAINER profile page.

The generic ingredient in STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There are one thousand and thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.

Summary for 018632

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018632

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER sterile water for injection LIQUID;N/A 018632 NDA Baxter Healthcare Company 0338-0013 0338-0013-29 5000 mL in 1 BAG (0338-0013-29)
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER sterile water for injection LIQUID;N/A 018632 NDA Baxter Healthcare Company 0338-0013 0338-0013-08 3000 mL in 1 BAG (0338-0013-08)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;N/AStrength100%
Approval Date:Jun 30, 1982TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:LIQUID;N/AStrength100%
Approval Date:Apr 19, 1988TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Teva
UBS
Argus Health
Citi
McKesson
Medtronic
Covington
US Department of Justice
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot